Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

TinniStop introduced to offer relief to tinnitus sufferers

By TinniStop | March 7, 2017

Over 50 million Americans who suffer from the debilitating symptoms of tinnitus can now find relief. TinniStop announced a new patent-pending medicine that relieves the ringing, buzzing and clicking in the ears. Thenatural medicine combines three little-known homeopathic remedies proven over decades to be highly effective. TinniStop has no side effects and requires no prescription. It is manufactured by an FDA-registered laboratory in the U.S.

Tinnitus, the hearing of sound when no external sound is present, is a chronic condition most frequently caused by years of exposure to loud noise. The Mayo Clinic estimates that over 20 percent of Americans suffer from tinnitus. There is no medical cure.

TinniStop’s product is based on homeopathic medicine — natural remedies made from highly diluted extracts of plants and minerals. The company says that the three ingredients in TinniStop have been shown, through decades of clinical use, to be effective in alleviating the symptoms of tinnitus. Conium maculatum reportedly relieves humming and buzzing, causticum is said to relieve ringing and roaring, and cocculus indicus reportedly relieves noise sensitivity.

FTC disputes that homeopathic treatments are effective.

(Source: PR Newswire)


Filed Under: Drug Discovery

 

Related Articles Read More >

New gonorrhea antibiotic could treat resistant infections
In door grow hemp. Cannabis at the beginning of flowering. Legal Marijuana cultivation in the home. Green background of leaves. Young cannabis plant. Medicinal indica with CBD.
Why Schedule III cannabis could be a win for Big Pharma
Red blood cells macro over red eritrosit background. Concept of blood cells count, medicine and healthcare. 3d rendering mock up
Platelet-inspired nanoparticle delivers drugs directly where they are needed
Lilly’s triple agonist delivers up to 71.2 lbs of weight loss in Phase 3 trial
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE